Rebound In COVID-19 Symptoms After Pfizer’s Antiviral Pill Might Be Due To Stronger Immune Response
Reports are circulating related to recurring COVID-19 symptoms after completing treatment and experiencing improvement after Pfizer Inc’s (NYSE:PFE) COVID-19 oral antiviral…